1. Frantz A.G., Weinberg D.L, Noel G.L. Studies on prolactin in man. Rec. Progr. Horm. Res. 28: 527, 1972.
2. Franks S., Nabarro J.D.N., Jacobs H.S. Prevalence and presentation of hyperprolactinemia in patients with “functionless” pituitary tumors. Lancet 1: 778, 1977.
3. Lamberts S.W.J. Klijn J.G.M., Kwa G.H., Birkenhager J.C. The dynamics of growth hormone and prolactin secre tion in acromegalic patients with “mixed” pituitary tu mors. Acta Endocrinol. (Kbh.) 90: 198, 1979.
4. Faglia G., Moriondo P., Beck-Peccoz P., Travaglini P., Ambrosi B., Spada A., Nissim M. Use of neuroactive drugs and hypothalamic regulatory hormones in the diagnosis of hyperprolactinemic states. In: Muller E.E. (Ed.), Neuroactive Drugs in Endocrinology, Developments in Endocrinology. Elsevier North Holland, Amsterdam, 1980, Vol. 9, p. 263.
5. Sherman B.M., Harris C.E., Schlecte J., Duello T.M., Halmi N.S., Van Gilder J., Chapler F.K., Granner D.K. Pathogenesis of prolactin secreting pituitary adenomas. Lancet 2: 1019, 1978.